The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
Abstract
Head and neck squamous cell carcinoma (HNSCC) comprises a heterogeneous group of tumors that arise from the squamous epithelium of the oral cavity, oropharynx, larynx and hypopharynx. While many HNSCCs are related to classical etiologic factors of smoking and alcohol, a clinically, genomically, and immunologically distinct subgroup of tumors arise from the epithelium of the tonsil and the base of tongue as a result of infection with Human Papilloma Virus (HPV). In this review we describe the genomic and immunologic landscape of HNSCC, highlighting differences between HPV-positive and HPV-negative HNSCC. While HPV-negative tumors are characterized by tobacco-associated mutations in genes including TP53 and CDKN2A, in HPV-positive HNSCC integration of viral genome from HPV into the host cellular genome results in expression of the E6 and E7 viral oncoproteins, with consequent degradation of p53 and functional inactivation of Rb. The immune microenvironment of HNSCC is characterized by changes in immune cell populations, immune checkpoints, as well as tumor or microenvironmental factors that alter the balance of the immune milieu in favor of immunosuppression, allowing tumor evasion and escape from immune surveillance. Immune therapies, in particular those targeting the PD1 receptor or its ligand PD-L1, including nivolumab, pembrolizumab, durvalumab, and atezolizumab have shown significant efficacy in subsets of patients with HNSCC. Current trials are evaluating the efficacy of these agents in combination with chemotherapy, radiotherapy and other immune therapies including CTLA-4 and IDO-1 inhibitors. While biomarkers including PD-L1 expression, PD-L2 expression and the interferon-gamma gene signature show potential to predict benefit from checkpoint inhibitor therapy - it is hoped that improved understanding of the genomic and immune landscape will lead to ways to improved strategies to stratify patients and to select which HNSCC are most likely to benefit from these therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602252 · Cited by 5,101
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 3,877
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Ayers, M., Lunceford, J., Nebozhyn, M., Murphy, E., Loboda, A., Kaufman, D. R., Albright, A., Cheng, J. D., Kang, S. P., Shankaran, V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91190 · Cited by 3,788
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.-R., Cupissol, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802656 · Cited by 3,726
Pignon, J.-P., Maître, A. L., Maillard, E., & Bourhis, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.04.014 · Cited by 3,069
Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A., & Gillison, M. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn011 · Cited by 2,779
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
Seiwert, T. Y., Burtness, B., Mehra, R., Weiss, J., Berger, R., Eder, J. P., Heath, K., McClanahan, T., Lunceford, J., Gause, C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30066-3 · Cited by 1,745
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Agrawal, N., Frederick, M. J., Pickering, C. R., Bettegowda, C., Chang, K., Li, R. J., Fakhry, C., Xie, T.-X., Zhang, J., Wang, J., et al. (2011) · Science · doi:10.1126/science.1206923 · Cited by 1,697
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
Chaturvedi, A. K., Anderson, W. F., Lortet-Tieulent, J., Curado, M. P., Ferlay, J., Franceschi, S., Rosenberg, P. S., Bray, F., & Gillison, M. L. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.3870 · Cited by 1,293
Ang, K. K., Berkey, B. A., Tu, X., Zhang, H. Z., Katz, R. L., Hammond, E. H., Fu, K. K., & Milas, L. (2002) · PubMed · Cited by 1,198
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
Grandis, J. R., Melhem, M. F., Gooding, W. E., Day, R., Holst, V. A., Wagener, M. M., Drenning, S. D., & Tweardy, D. J. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.824 · Cited by 1,113
Chow, L. Q. M., Haddad, R., Gupta, S., Mahipal, A., Mehra, R., Tahara, M., Berger, R., Eder, J. P., Burtness, B., Lee, S.-H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.1478 · Cited by 857
Brandwein-Gensler, M., Teixeira, M. S., Lewis, C. M., Lee, B., Rolnitzky, L., Hille, J. J., Genden, E., Urken, M. L., & Wang, B. Y. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000149687.90710.21 · Cited by 831
TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck
Poeta, M. L., Manola, J., Goldwasser, M. A., Forastiere, A., Benoit, N., Califano, J. A., Ridge, J. A., Goodwin, J., Kenady, D., Saunders, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073770 · Cited by 817
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Self-citationLyford-Pike, S., Peng, S., Young, G. D., Taube, J. M., Westra, W. H., Akpeng, B., Bruno, T. C., Richmon, J. D., Wang, H., Bishop, J. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2384 · Cited by 777
The head and neck cancer immune landscape and its immunotherapeutic implications
Mandal, R., Şenbabaoğlu, Y., Desrichard, A., Havel, J. J., Dalin, M. G., Riaz, N., Lee, K.-W., Ganly, I., Hakimi, A. A., Chan, T. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89829 · Cited by 765
Rischin, D., Young, R. J., Fisher, R., Fox, S. B., Le, Q.-T., Peters, L. J., Solomon, B., Choi, J., O'Sullivan, B., Kenny, L. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2904 · Cited by 737
Self-citationThe global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012
Shield, K. D., Ferlay, J., Jemal, A., Sankaranarayanan, R., Chaturvedi, A. K., Bray, F., & Soerjomataram, I. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21384 · Cited by 724
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000162 · Cited by 709
Self-citationClonal status of actionable driver events and the timing of mutational processes in cancer evolution
McGranahan, N., Favero, F., de Bruin, E. C., Birkbak, N. J., Szallasi, Z., & Swanton, C. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1408 · Cited by 685
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00112-6 · Cited by 678
Immunology and Immunotherapy of Head and Neck Cancer
Ferris, R. L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.1509 · Cited by 668
Bauml, J., Seiwert, T. Y., Pfister, D. G., Worden, F., Liu, S. V., Gilbert, J., Saba, N. F., Weiss, J., Wirth, L., Sukari, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1524 · Cited by 663
Seiwert, T. Y., Zuo, Z., Keck, M. K., Khattri, A., Pedamallu, C. S., Stricker, T., Brown, C., Pugh, T. J., Stojanov, P., Cho, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3310 · Cited by 657
Badoual, C., Hans, S., Merillon, N., Van Ryswick, C., Ravel, P., Benhamouda, N., Levionnois, E., Nizard, M., Si-Mohamed, A., Besnier, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2606 · Cited by 633
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 598
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
Yearley, J. H., Gibson, C., Yu, N., Moon, C., Murphy, E., Juco, J., Lunceford, J., Cheng, J., Chow, L. Q. M., Seiwert, T. Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1761 · Cited by 594
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
Lui, V. W. Y., Hedberg, M. L., Li, H., Vangara, B. S., Pendleton, K., Zeng, Y., Lu, Y., Zhang, Q., Du, Y., Gilbert, B. R., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0103 · Cited by 589
Pickering, C. R., Zhang, J., Yoo, S. Y., Bengtsson, L., Moorthy, S., Neskey, D. M., Zhao, M., Ortega Alves, M. V., Chang, K., Drummond, J., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0537 · Cited by 559
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
Strome, S. E., Dong, H., Tamura, H., Voss, S. G., Flies, D. B., Tamada, K., Salomão, D. R., Cheville, J. C., Hirano, F., Lin, W. Y., et al. (2003) · PubMed · Cited by 489
Harrington, K. J., Ferris, R. L., Blumenschein, G., Colevas, A. D., Fayette, J., Licitra, L., Kasper, S., Even, C., Vokes, E. E., Worden, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30421-7 · Cited by 428
Mroz, E. A., & Rocco, J. W. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2012.09.007 · Cited by 417
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
Ward, M. J., Thirdborough, S. M., Mellows, T., Riley, C., Harris, S., Suchak, K., Webb, A., Hampton, C., Patel, N. N., Randall, C. J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.639 · Cited by 391
Keck, M. K., Zuo, Z., Khattri, A., Stricker, T. P., Brown, C. D., Imanguli, M., Rieke, D., Endhardt, K., Fang, P., Brägelmann, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2481 · Cited by 370
Henderson, S., Chakravarthy, A., Su, X., Boshoff, C., & Fenton, T. R. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.012 · Cited by 345
Balermpas, P., Michel, Y., Wagenblast, J., Seitz, O., Weiss, C., Rödel, F., Rödel, C., & Fokas, E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.640 · Cited by 309
Mroz, E. A., Tward, A. M., Hammon, R. J., Ren, Y., & Rocco, J. W. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001786 · Cited by 290
Jie, H.-B., Gildener-Leapman, N., Li, J., Srivastava, R. M., Gibson, S. P., Whiteside, T. L., & Ferris, R. L. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.645 · Cited by 286
Pak, A. S., Wright, M. A., Matthews, J. P., Collins, S. L., Petruzzelli, G. J., & Young, M. R. I. (1995) · PubMed · Cited by 271
Jie, H.-B., Schuler, P. J., Lee, S. C., Srivastava, R. M., Argiris, A., Ferrone, S., Whiteside, T. L., & Ferris, R. L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2788 · Cited by 266
Weed, D. T., Vella, J. L., Reis, I. M., De la fuente, A. C., Gomez, C., Sargi, Z., Nazarian, R., Califano, J., Borrello, I., & Serafini, P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1711 · Cited by 261
Kim, H. R., Ha, S.-J., Hong, M. H., Heo, S. J., Koh, Y. W., Choi, E. C., Kim, E. K., Pyo, K. H., Jung, I., Seo, D., et al. (2016) · Scientific Reports · doi:10.1038/srep36956 · Cited by 256
Cho, Y.-A., Yoon, H.-J., Lee, J.-I., Hong, S.-P., & Hong, S.-D. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.08.007 · Cited by 245
Herbst, R. S., Gandara, D. R., Hirsch, F. R., Redman, M. W., LeBlanc, M., Mack, P. C., Schwartz, L. H., Vokes, E., Ramalingam, S. S., Bradley, J. D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3473 · Cited by 244
High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
Lin, Y.-M., Sung, W.-W., Hsieh, M.-J., Tsai, S.-C., Lai, H.-W., Yang, S.-M., Shen, K.-H., Chen, M.-K., Lee, H., Yeh, K.-T., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142656 · Cited by 231
Morris, L. G. T., Chandramohan, R., West, L., Zehir, A., Chakravarty, D., Pfister, D. G., Wong, R. J., Lee, N. Y., Sherman, E. J., Baxi, S. S., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1790 · Cited by 223
Ferris, R. L., Whiteside, T. L., & Ferrone, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2750 · Cited by 221
Vassilakopoulou, M., Avgeris, M., Velcheti, V., Kotoula, V., Rampias, T., Chatzopoulos, K., Perisanidis, C., Kontos, C. K., Giotakis, A. I., Scorilas, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1543 · Cited by 212
Reichert, T. E., Strauss, L., Wagner, E. M., Gooding, W. E., & Whiteside, T. L. (2002) · PubMed · Cited by 211
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
Hedberg, M. L., Goh, G., Chiosea, S. I., Bauman, J. E., Freilino, M. L., Zeng, Y., Wang, L., Diergaarde, B. B., Gooding, W. E., Lui, V. W. Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82066 · Cited by 200
Balermpas, P., Rödel, F., Rödel, C., Krause, M., Linge, A., Lohaus, F., Baumann, M., Tinhofer, I., Budach, V., Gkika, E., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29683 · Cited by 199
Näsman, A., Romanitan, M., Nordfors, C., Grün, N., Johansson, H., Hammarstedt, L., Marklund, L., Munck-Wikland, E., Dalianis, T., & Ramqvist, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038711 · Cited by 199
Nordfors, C., Grün, N., Tertipis, N., Ährlund-Richter, A., Haeggblom, L., Sivars, L., Du, J., Nyberg, T., Marklund, L., Munck-Wikland, E., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.019 · Cited by 197
Wolf, G. T., Chepeha, D. B., Bellile, E., Nguyen, A., Thomas, D., & McHugh, J. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2014.09.006 · Cited by 190
Costa, N. L., Valadares, M. C., Souza, P. P. C., Mendonça, E. F., Oliveira, J. C., Silva, T. A., & Batista, A. C. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2012.09.012 · Cited by 188
Deng, W.-W., Mao, L., Yu, G.-T., Bu, L.-L., Ma, S.-R., Liu, B., Gutkind, J. S., Kulkarni, A. B., Zhang, W.-F., & Sun, Z.-J. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1239005 · Cited by 172
Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers
Vanpouille-Box, C., Formenti, S. C., & Demaria, S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0037 · Cited by 171
Marcus, B., Arenberg, D., Lee, J., Kleer, C., Chepeha, D. B., Schmalbach, C. E., Islam, M., Paul, S., Pan, Q., Hanash, S., et al. (2004) · Cancer · doi:10.1002/cncr.20701 · Cited by 163
Davis, R. J., Van Waes, C., & Allen, C. T. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.05.002 · Cited by 163
Straub, M., Drecoll, E., Pfarr, N., Weichert, W., Langer, R., Hapfelmeier, A., Götz, C., Wolff, K.-D., Kolk, A., & Specht, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7593 · Cited by 161
Young, M. R. I., Wright, M. A., Lozano, Y., Prechel, M. M., Benefield, J., Leonetti, J. P., Collins, S. L., & Petruzzelli, G. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<69::aid-ijc12>3.0.co;2-d · Cited by 160
Watanabe, Y., Katou, F., Ohtani, H., Nakayama, T., Yoshie, O., & Hashimoto, K. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.12.015 · Cited by 160
Oguejiofor, K., Hall, J., Slater, C., Betts, G. N. J., Hall, G. L., Slevin, N. J., Dovedi, S. J., Stern, P. L., & West, C. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.277 · Cited by 149
Kim, H. S., Lee, J. Y., Lim, S. H., Park, K., Sun, J., Ko, Y. H., Baek, C., Son, Y., Jeong, H. S., Ahn, Y. C., et al. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2015.249 · Cited by 136
Ukpo, O. C., Thorstad, W. L., & Lewis, J. S. (2012) · Head and Neck Pathology · doi:10.1007/s12105-012-0406-z · Cited by 128
Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma.
Russell, S., Angell, T., Lechner, M. G., Liebertz, D., Correa, A., Sinha, U. K., Kokot, N., & Epstein, A. (2013) · PubMed · Cited by 124
Wood, O., Woo, J., Seumois, G., Savelyeva, N., McCann, K. J., Singh, D. K., Jones, T. M., Peel, L., Breen, M. S., Ward, M. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10788 · Cited by 119
Ferris, R. L., Hunt, J. L., & Ferrone, S. (2005) · Immunologic Research · doi:10.1385/ir:33:2:113 · Cited by 117
Oliveira–Costa, J. P., de Carvalho, A. F., da Silveira, G. G., Amaya, P., Wu, Y., Park, K. J., Pinilla, M. G., Lustberg, M. B., Buim, M. E. C., Ferreira, E. N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3939 · Cited by 116
Kikuchi, M., Clump, D. A., Srivastava, R. M., Sun, L., Zeng, D., Díaz-Pérez, J. A., Anderson, C. J., Edwards, W. B., & Ferris, R. L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1329071 · Cited by 115
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.
Uppaluri, R., Dunn, G. P., & Lewis, J. S. (2008) · PubMed · Cited by 112
Jie, H.-B., Srivastava, R. M., Argiris, A. E., Bauman, J. E., Kane, L., & Ferris, R. L. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0333 · Cited by 106
Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell Carcinomas
Hammerman, P. S., Hayes, D. N., & Grandis, J. R. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1205 · Cited by 105
Perez, R. P., Riese, M. J., Lewis, K. D., Saleh, M. N., DAUD, A. I., Berlin, J. D., Lee, J. J., Mukhopadhyay, S., Zhou, L., Serbest, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.3003 · Cited by 95
Young, R. J., Rischin, D., Fisher, R., McArthur, G. A., Fox, S. B., Peters, L. J., Corry, J. F., Lim, A. M. L., Waldeck, K., & Solomon, B. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1262 · Cited by 93
Self-citationCohen, E. E. W., Harrington, K. J., Tourneau, C. L., Dinis, J., Licitra, L. F., Ahn, M.-J., Soria, A., Machiels, J.-P., Mach, N., Mehra, R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx440.040 · Cited by 91
Bell, R. B., Leidner, R. S., Crittenden, M. R., Curti, B. D., Feng, Z., Montler, R. D., Gough, M. J., Fox, B. A., Weinberg, A. D., & Urba, W. J. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.009 · Cited by 72
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
Hedberg, M. L., Goh, G., Chiosea, S. I., Bauman, J. E., Freilino, M. L., Zeng, Y., Wang, L., Diergaarde, B. B., Gooding, W. E., Lui, V. W. Y., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86862 · Cited by 72
Satgunaseelan, L., Gupta, R., Madore, J., Chia, N., Lum, T., Palme, C. E., Boyer, M. J., Scolyer, R. A., & Clark, J. R. (2016) · Pathology · doi:10.1016/j.pathol.2016.07.003 · Cited by 71
Meulenaere, A. D., Vermassen, T., Aspeslagh, S., Deron, P. B., Duprez, F., Laukens, D., Dorpe, J. V., Ferdinande, L., & Rottey, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19045 · Cited by 71
Concha‐Benavente, F., Srivastava, R. M., Ferrone, S., & Ferris, R. L. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.05.008 · Cited by 70
TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?
Meulenaere, A. D., Vermassen, T., Aspeslagh, S., Vandecasteele, K., Rottey, S., & Ferdinande, L. (2016) · Head and Neck Pathology · doi:10.1007/s12105-016-0776-8 · Cited by 67
Lara, P. N., Bauer, T. M., Hamid, O., Smith, D. C., Gajewski, T. F., Gangadhar, T. C., Somer, B. G., Schmidt, E. V., Zhao, Y., Gowda, H. N., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.4515 · Cited by 67
Czystowska, M., Gooding, W. E., Szczepański, M. J., Lopez-Abaitero, A., Ferris, R. L., Johnson, J. T., & Whiteside, T. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2191 · Cited by 65
Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers
Wallis, S. P., Stafford, N. D., & Greenman, J. (2014) · Head & Neck · doi:10.1002/hed.23736 · Cited by 63
Decreased NK Cells in Patients with Head and Neck Cancer Determined in Archival DNA
Accomando, W. P., Wiencke, J. K., Houseman, E. A., Butler, R. A., Zheng, S., Nelson, H. H., & Kelsey, K. T. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1008 · Cited by 62
Bauman, J. E., Cohen, E. E. W., Ferris, R. L., Adelstein, D. J., Brizel, D. M., Ridge, J. A., O’Sullivan, B., Burtness, B. A., Butterfield, L. H., Carson, W. E., et al. (2016) · Cancer · doi:10.1002/cncr.30449 · Cited by 51
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
Goltz, D., Gevensleben, H., Dietrich, J., Schröck, F., de Vos, L., Droege, F., Kristiansen, G., Schroeck, A., Landsberg, J., Bootz, F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17354 · Cited by 50
Wulff, S., Pries, R., Börngen, K., Trenkle, T., & Wollenberg, B. (2009) · PubMed · Cited by 49
Meulenaere, A. D., Vermassen, T., Aspeslagh, S., Huvenne, W., Dorpe, J. V., Ferdinande, L., & Rottey, S. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.05.002 · Cited by 48
Green, V. L., Michno, A., Stafford, N. D., & Greenman, J. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1395-9 · Cited by 36
Zandberg, D. P., Algazi, A. P., Jimeno, A., Good, J., Fayette, J., Bouganim, N., Ready, N., Clement, P., Goswmi, T., Jarkowski, A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx374 · Cited by 31
Young, R., Lim, A., Angel, C., Collins, M., Deb, S., Corry, J., Wiesenfeld, D., Kleid, S., Sigston, E., Lyons, B., et al. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.01.006 · Cited by 30
Self-citationWeeden, C. E., Holik, A. Z., Young, R. J., Ma, S. B., Garnier, J.-M., Fox, S. B., Antippa, P. N., Irving, L. B., Steinfort, D., Wright, G. M., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0174 · Cited by 25
Self-citationBahleda, R., Braiteh, F. S., Balmanoukian, A. S., Braña, I., Hodi, F. S., Garbo, L. E., Liu, B., Molinero, L. L., O'Hear, C. E., Shen, X., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx374.001a · Cited by 25
Cited by
Pattern recognition receptors in health and diseases
Li, D., & Wu, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00687-0 · Cited by 1,787
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 831
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Alsahafi, E., Begg, K., Amelio, I., Raulf, N., Lucarelli, P., Sauter, T., & Tavassoli, M. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1769-9 · Cited by 525
Modern radiotherapy for head and neck cancer
Alterio, D., Marvaso, G., Ferrari, A., Volpe, S., Orecchia, R., & Jereczek-Fossa, B. A. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.07.002 · Cited by 295
Biomarkers for immunotherapy response in head and neck cancer
Gavrielatou, N., Doumas, S., Economopoulou, P., Foukas, P. G., & Psyrri, A. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.101977 · Cited by 256
Metadata
- Authors
- Solomon, B., Young, R. J., & Rischin, D.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 52
- Issue
- Pt 2
- Pages
- 228-240
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2788371883
- Cited by
- 467
- References
- 103
- FWCI
- 29.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.